Paper ยท 25417114
Integrated genomic characterization of papillary thyroid carcinoma.
Cancer Genome Atlas Research Network. Cell, 2014. Cited by 2,513 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Integrated genomic characterization of papillary thyroid carcinoma. Papers, record 25417114. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25417114
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Mutation | Major topic |
| Thyroid Neoplasms | Major topic |
| Carcinoma, Papillary | |
| DNA Copy Number Variations | |
| Gene Fusion | |
| Humans | |
| Thyroid Cancer, Papillary | |
| Thyroid Gland |
Source PubMed
Grants41
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30CA16672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| UL1 TR000005 | NCATS NIH HHS | United States | UL1TR000005 | PubMed and NIH | NIH RePORTER |
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| 5U24CA143843 | NCI NIH HHS | United States | U24CA143843 | PubMed and NIH | NIH RePORTER |
| U24 CA143882 | NCI NIH HHS | United States | U24CA143882 | PubMed and NIH | NIH RePORTER |
| U54 HG003067 | NHGRI NIH HHS | United States | U54HG003067 | PubMed and NIH | NIH RePORTER |
| U54HG003273 | NHGRI NIH HHS | United States | U54HG003273 | PubMed and NIH | NIH RePORTER |
| U24 CA143835 | NCI NIH HHS | United States | U24CA143835 | PubMed and NIH | NIH RePORTER |
| 5U24CA143840 | NCI NIH HHS | United States | U24CA143840 | PubMed and NIH | NIH RePORTER |
| P30 CA046592 | NCI NIH HHS | United States | P30CA046592 | PubMed and NIH | NIH RePORTER |
1 to 10 of 41
See all 41 grantsTrials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05752669 | Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer. | Background | ClinicalTrials.gov | |
| NCT06133374 | Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples | Background | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 25,384,944 | Genetics: The Cancer Genome Atlas maps papillary thyroid cancer. | https://conductscience.org/library/papers/25384944 | PubMed |
| Comment in | 25,421,371 | Genetics: The genomic landscape of papillary thyroid carcinoma. | https://conductscience.org/library/papers/25421371 | PubMed |
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,079,833 | MicroRNAs in cancer. | Annu Rev Pathol | 2014 | https://conductscience.org/library/papers/24079833 | PubMed |
| 2 | 24,248,188 | The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. | J Clin Endocrinol Metab | 2014 | https://conductscience.org/library/papers/24248188 | PubMed |
| 3 | 24,423,287 | Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype. | J Clin Endocrinol Metab | 2014 | https://conductscience.org/library/papers/24423287 | PubMed |
| 4 | 23,571,588 | Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. | JAMA | 2013 | https://conductscience.org/library/papers/23571588 | PubMed |
| 5 | 23,422,095 | New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23422095 | PubMed |
| 6 | 23,533,233 | Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. | J Clin Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23533233 | PubMed |
| 7 | 23,649,806 | Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint. | J Cell Biol | 2013 | https://conductscience.org/library/papers/23649806 | PubMed |
| 8 | 23,625,203 | BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma. | Endocr Pathol | 2013 | https://conductscience.org/library/papers/23625203 | PubMed |
| 9 | 10,958,784 | PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. | Science | 2000 | https://conductscience.org/library/papers/10958784 | PubMed |
| 10 | 25,166,867 | Guided visual exploration of genomic stratifications in cancer. | Nat Methods | 2014 | https://conductscience.org/library/papers/25166867 | PubMed |
1 to 10 of 71
See all 71 referencesCited by1,740
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,513 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,963,735 | Single-cell RNA-seq reveals SPP1+ tumor-associated macrophage population associated with collagen remodeling in anaplastic thyroid cancer. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42963735 | PubMed |
| 42,959,152 | Isolated TERT promoter mutation may define a high-risk prognostic subgroup in papillary thyroid carcinoma: an exploratory, hypothesis-generating analysis of TCGA and GSE33630 datasets. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42959152 | PubMed |
| 42,952,532 | Diagnostic performance of next-generation sequencing in thyroid nodules and molecular correlates of tumor aggressiveness in papillary thyroid carcinoma. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42952532 | PubMed |
| 42,938,938 | Transcriptomic Convergence Reveals Tumour-Specific Stromal Remodelling in Immune-Enriched Papillary Thyroid Carcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938938 | PubMed |
| 42,938,348 | Long Non-Coding RNA LINC01614 Promotes Aggressive Phenotypes and Ferroptosis Resistance in Papillary Thyroid Cancer Through a Putative miR-4521/IGF2/PI3K-AKT Signaling Axis. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42938348 | PubMed |
| 42,934,462 | IGF2BP3-Overexpressing Follicular Cell-derived Thyroid Tumors Consist of Low-risk Follicular Patterned Tumors with Frequent HBME-1 Negativity and Distinct Cytomorphologic Features. | Endocr Pathol | 2026 | https://conductscience.org/library/papers/42934462 | PubMed |
| 42,922,834 | Cross-scale genetic, molecular, and cellular triangulation prioritizes ACSL5 as a T3-responsive candidate linking hypothyroidism liability to anemia. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42922834 | PubMed |
| 42,919,442 | Oncogenic RAS as an adaptive signaling ecosystem: context-dependent vulnerabilities and resistance-informed therapeutic design. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42919442 | PubMed |
| 42,919,130 | meth-SemiCancer2: a cancer subtyping framework leveraging domain adaptation with contrastive learning for batch effect correction in DNA methylation profiles. | BMC Bioinformatics | 2026 | https://conductscience.org/library/papers/42919130 | PubMed |
| 42,909,234 | Comparative clinical and molecular profiling of papillary thyroid carcinomas with unilateral and bilateral lateral lymph node metastasis: a retrospective cohort study. | Ann Surg Treat Res | 2026 | https://conductscience.org/library/papers/42909234 | PubMed |
1 to 10 of 1,740
See all 1,740 cited byGenes82
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 | NCBI Gene |
| ARAF | 369 | PubTator's text mining | https://conductscience.org/library/genes/369 | NCBI Gene |
| ARID1B | 57,492 | PubTator's text mining | https://conductscience.org/library/genes/57492 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| BDP1 | 55,814 | PubTator's text mining | https://conductscience.org/library/genes/55814 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
1 to 10 of 82
See all 82 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25417114
GET https://conductscience.org/api/papers/v1/25417114/grants?page=2